Dipasquale, V.
95  results:
Search for persons X
?
 
?
3

P570 Efficacy and safety of Adalimumab in Very Early-onset ..:

Weintraub, Y ; Collen Veit, L ; Hussey, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1114-i1115 , 2024
 
?
4

P885 Pharmacokinetics, pharmacodynamics, and immunogenicity..:

Dipasquale, V ; Alibrandi, A ; Pellegrino, S..
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1628-i1628 , 2024
 
?
6

P20.06.B SYSTEMIC CHEMOTHERAPY IN ADULT PATIENTS WITH DIFFU..:

Lombardi, G ; Simonelli, M ; Minniti, G...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii127-ii128 , 2023
 
?
7

P263 Very early onset Inflammatory Bowel Diseases: Review o..:

Gramaglia, S M C ; Cucinotta, U ; Dipasquale, V...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i304-i304 , 2022
 
?
8

P436 Efficacy and safety of biosimilars of anti-TNF-a in pa..:

Dipasquale, V ; Pellegrino, S ; Cucinotta, U...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i419-i419 , 2022
 
?
 
?
10

DOP66 Disease course of Ulcerative proctitis in children: A..:

Martinelli, M ; Fedele, F ; Romano, C...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i110-i111 , 2022
 
?
11

P300 Very early onset Inflammatory Bowel Diseases: Review o..:

Gramaglia, S M C ; Cucinotta, U ; Dipasquale, V...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i330-i330 , 2022
 
?
14

Definition of the Prognostic Role of MGMT Promoter Methylat..:

Caccese M ; Simonelli M ; Villani V...
info:eu-repo/semantics/altIdentifier/wos/WOS:000802408100001.  , 2022
 
?
15

Biosimilars in Pediatric IBD: Updated Considerations for Di..:

Dipasquale V ; Cucinotta U ; Romano C
https://www.dovepress.com/biosimilars-in-pediatric-ibd-updated-considerations-for-disease-manage-peer-reviewed-fulltext-article-BTT.  , 2022
 
1-15